FDA Drug recall D-0360-2019
Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, L…
- FDA Drug
- Class I
- terminated
- Published 2018-12-26
On 2018-12-26 the FDA classified a Class I recall of Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, L… by Results Rna, citing lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0360-2019 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2018-12-14 |
| Published | 2018-12-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Results Rna |
| Distribution | US |
Product
Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4
Reason
Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver
Identifiers
| upc | 792382307234 |
|---|---|
| code_info | All Lots |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0360-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.